These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1675 related items for PubMed ID: 19371819

  • 1. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER, Basile JD.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [Abstract] [Full Text] [Related]

  • 2. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
    Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, Hughes PJ, Michalowicz BS, Leach JW, Swenson KK, Swift JQ, Adkinson C, Basi DL.
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
    [Abstract] [Full Text] [Related]

  • 4. The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw.
    Wilde F, Heufelder M, Winter K, Hendricks J, Frerich B, Schramm A, Hemprich A.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Feb; 111(2):153-63. PubMed ID: 20674411
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.
    Stanton DC, Balasanian E.
    J Oral Maxillofac Surg; 2009 May; 67(5):943-50. PubMed ID: 19375001
    [Abstract] [Full Text] [Related]

  • 9. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
    Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J.
    J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
    [Abstract] [Full Text] [Related]

  • 10. Bisphosphonate-related osteonecrosis of the jaws--an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma.
    Curi MM, Cossolin GS, Koga DH, Zardetto C, Christianini S, Feher O, Cardoso CL, dos Santos MO.
    J Oral Maxillofac Surg; 2011 Sep; 69(9):2465-72. PubMed ID: 21763050
    [Abstract] [Full Text] [Related]

  • 11. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
    Dodson TB.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
    [Abstract] [Full Text] [Related]

  • 12. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
    Vescovi P, Nammour S.
    Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
    [Abstract] [Full Text] [Related]

  • 13. Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review.
    Hewitt C, Farah CS.
    J Oral Pathol Med; 2007 Jul; 36(6):319-28. PubMed ID: 17559492
    [Abstract] [Full Text] [Related]

  • 14. [Encounter of cancer cells with bone. Present status and problems in occurrence of bisphosphonate-related osteonecrosis of the jaws].
    Urade M.
    Clin Calcium; 2011 Mar; 21(3):420-7. PubMed ID: 21358064
    [Abstract] [Full Text] [Related]

  • 15. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 16. Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients: a challenging problem.
    Eckardt AM, Lemound J, Lindhorst D, Rana M, Gellrich NC.
    Anticancer Res; 2011 Jun; 31(6):2313-8. PubMed ID: 21737657
    [Abstract] [Full Text] [Related]

  • 17. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I, Magopoulos C, Karakasis D.
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
    [Abstract] [Full Text] [Related]

  • 18. Treatment results of bisphosphonate-related osteonecrosis of the jaws.
    Wutzl A, Biedermann E, Wanschitz F, Seemann R, Klug C, Baumann A, Watzinger F, Schicho K, Ewers R, Millesi G.
    Head Neck; 2008 Sep; 30(9):1224-30. PubMed ID: 18642292
    [Abstract] [Full Text] [Related]

  • 19. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT, Chiang WF, Chuang CY, Chang SW.
    J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
    [Abstract] [Full Text] [Related]

  • 20. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.
    Allen MR, Burr DB.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):61-70. PubMed ID: 19371816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 84.